Vascular | STRAVIX

Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.¹

Using BioTissue matrices for Vascular Surgery

Natural extracellular matrix that’s stronger than amnion.¹
Has an adhesive barrier to protect delicate tissues during recovery.¹
Supports a faster, healthier recovery for a wide range of conditions.^2-4
Helps reduce the risk of complications.^2-4

Clinical applications with BioTissue matrices

Fasciotomy
Venous leg ulcers (VLUs)

Case study

Fasciotomy Closure with STRAVIX Tissue

1 week post fasciotomy and NPWT

OR visit 1 week post fasciotomy

Stitching together and pie crusting two 3x6 STRAVIX Tissue

STRAVIX Tissue affixed with staples

2 weeks post STRAVIX Tissue application. Typical caramelization noted; no clinical signs of infection. Rapid formation of granulation tissue, and size reduction.

2 months post application

Closure: 5 months post STRAVIX Tissue application

A 58-year-old male with a history of smoking, DM, HTN, and HCL presented with acute limb ischemia. A CT scan confirmed an occluded SFA and popliteal artery.

The patient underwent an urgent thrombectomy and a 4-compartment fasciotomy, revealing exceptionally swollen muscle. After 1 week of NPWT, swelling decreased, and definitive reconstruction was performed using two 3x6 STRAVIX Tissues stitched together and stapled. At 2 weeks post-application, the wound showed rapid granulation and size reduction with no signs of infection. NPWT was continued.

The patient was followed in-office and by a visiting nurse. Complete closure was achieved 5 months post-STRAVIX application, leaving the patient wound free, pain free, and ambulatory.

Case study

Fasciotomy Closure with STRAVIX Tissue

1 week post fasciotomy and NPWT

OR visit 1 week post fasciotomy

Stitching together and pie crusting two 3x6 STRAVIX Tissue

STRAVIX Tissue affixed with staples

2 weeks post STRAVIX Tissue application. Typical caramelization noted; no clinical signs of infection. Rapid formation of granulation tissue, and size reduction.

2 months post application

Closure: 5 months post STRAVIX Tissue application

A 58-year-old male with a history of smoking, DM, HTN, and HCL presented with acute limb ischemia. A CT scan confirmed an occluded SFA and popliteal artery.

The patient was followed in-office and by a visiting nurse. Complete closure was achieved 5 months post-STRAVIX application, leaving the patient wound free, pain free, and ambulatory.

Smith+Nephew BioTissue portfolio

Our comprehensive BioTissue solutions support a range of specialties that require advanced incision care. See the full scope of application today.

STRAVIX^◊

Cryopreserved Umbilical Tissue

STRAVIX PL^◊

Lyopreserved Umbilical Tissue

GRAFIX XC^◊

Cryopreserved Placental Membrane

GRAFIX XC PL^◊

Lyopreserved Umbilical Tissue

OASIS

Matrix products

STRAVIX^◊

Cryopreserved Umbilical Tissue

STRAVIX PL^◊

Lyopreserved Umbilical Tissue

GRAFIX XC^◊

Cryopreserved Placental Membrane

GRAFIX XC PL^◊

Lyopreserved Umbilical Tissue

OASIS

Matrix products

References:

Data on file at Osiris Therapeutics, Inc.
Brandeisky J, Kurtz Phelan DH. Clinical outcome of Achilles tendon repair using viable intact cryopreserved umbilical tissue versus standard of care. Wounds. 2017; 29(11): E111-E114.
Sundblad KW, Tassis EK. A quality improvement pilot assessment of the safety and associated.
McGinness K, Kurtz Phelan DH. Use of viable cryopreserved umbilical tissue for so tissue defects in patients with gas gangrene: A case series. Wounds. 2018; 30(4): 90-95.

Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.1

Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.1

Using BioTissue matrices for Vascular Surgery

Clinical applications with BioTissue matrices

Case study

Fasciotomy Closure with STRAVIX Tissue

Case study

Fasciotomy Closure with STRAVIX Tissue

Smith+Nephew BioTissue portfolio

STRAVIX◊

STRAVIX PL◊

GRAFIX XC◊

GRAFIX XC PL◊

OASIS

STRAVIX◊

STRAVIX PL◊

GRAFIX XC◊

GRAFIX XC PL◊

OASIS

Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.¹

Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.¹

STRAVIX^◊

STRAVIX PL^◊

GRAFIX XC^◊

GRAFIX XC PL^◊

STRAVIX^◊

STRAVIX PL^◊

GRAFIX XC^◊

GRAFIX XC PL^◊